Drawing for INTERNATIONAL BRACHYTHERAPY

USPTO serial 75530286

INTERNATIONAL BRACHYTHERAPY

Reviewed by CopyMark Law Group

Reg. 2486359Status 710
Filing date
Status date
Registration date
Sep 4, 2001
Examiner
CLARK, GLENN
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTERNATIONAL BRACHYTHERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GERRY J. ELMAN

GERRY J. ELMAN Elman Technology Law, P.C.406 Yale AvenueP.O. Box 209Swarthmore, PA 19081

Goods and services

ClassDescriptionStatusFirst use
010House mark for medical devices, namely, radiotherapy medical devicesSECTION 8 - CANCELLEDAug 1, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 6, 2012CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Sep 14, 20078.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Sep 11, 2007PLGLASSIGNED TO PARALEGAL—
Aug 23, 20078.AFREGISTERED - SEC. 8 (6-YR) FILED—
Aug 23, 2007ES8RTEAS SECTION 8 RECEIVED—
Feb 1, 2007CFITCASE FILE IN TICRS—
Apr 6, 2002COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 28, 2001AMD7SEC 7 REQUEST FILED—
Sep 4, 2001R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Mar 6, 2001CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Mar 6, 2001IUAAUSE AMENDMENT ACCEPTED—
Feb 27, 2001CNEAEXAMINER'S AMENDMENT MAILED—
Feb 14, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2000AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Aug 22, 2000IUAFUSE AMENDMENT FILED—
Feb 23, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 1, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 1999DOCKASSIGNED TO EXAMINER—
Mar 25, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance